Using CRISPR cas-9 to treat cancer: A Review

Abstract

CRISPR-Cas9 technology has rapidly emerged as a versatile tool in genetic engineering, offering precise gene editing capabilities with unprecedented accuracy and efficiency. Originally discovered as a microbial defense mechanism(1), CRISPR-Cas9 has been ingeniously repurposed by scientists to target and modify specific genes within the human genome. This groundbreaking technology holds immense promise in significantly impacting cancer treatment by enabling the selective editing of genes associated with tumorigenesis and drug resistance, potentially leading to more effective therapeutic interventions. In this article, we provide a comprehensive review of the current landscape of CRISPR-Cas9 applications in cancer research and treatment, highlighting its transformative potential in combating this formidable disease (2).